Keith Kucinski
Director of Finance/CFO bei MATINAS BIOPHARMA HOLDINGS, INC.
Vermögen: 25 610 $ am 31.03.2024
Profil
Keith A.
Kucinski is currently the Chief Financial Officer at Matinas BioPharma Holdings, Inc. He previously held positions as Senior Director-Finance & Corporate Development at Barr Pharmaceuticals, Inc. from 2002 to 2009, Treasurer & Vice President at Endo Generics Holdings, Inc. from 2009 to 2015, and Chief Financial Officer at Remedy One in 2018.
Kucinski received his undergraduate degree from the University of Notre Dame and his MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 94 500 ( 0,04% ) | 25 610 $ | 31.03.2024 |
Aktive Positionen von Keith Kucinski
| Unternehmen | Position | Beginn |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Director of Finance/CFO | 03.01.2019 |
Ehemalige bekannte Positionen von Keith Kucinski
| Unternehmen | Position | Ende |
|---|---|---|
Remedy One
 Remedy One Information Technology ServicesTechnology Services Remedy One is a healthcare industry change agent that aims to improve outcomes for health plans, employers, pharmaceutical manufacturers, PBMs, and patients. The private company is based in Collinsville, CT. The company leverages the experience of its healthcare professionals to achieve this goal. Remedy One cuts through the complexity of modern pharmaceutical programs to uncover opportunities to grow, flex agreements in your favor, and help you take decisive action on what matters. | Director of Finance/CFO | 01.09.2018 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Treasurer | 01.10.2015 |
| BARR PHARMACEUTICALS INC | Corporate Officer/Principal | 01.05.2009 |
Ausbildung von Keith Kucinski
| University of Notre Dame | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Barr Pharmaceuticals, Inc.
 Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Barr Pharmaceuticals, Inc. manufactures and sells generic prescription pharmaceutical products. The company was founded in 1970 and is headquartered in Montvale, NJ. | Health Technology |
Remedy One
Remedy One Information Technology ServicesTechnology Services Remedy One is a healthcare industry change agent that aims to improve outcomes for health plans, employers, pharmaceutical manufacturers, PBMs, and patients. The private company is based in Collinsville, CT. The company leverages the experience of its healthcare professionals to achieve this goal. Remedy One cuts through the complexity of modern pharmaceutical programs to uncover opportunities to grow, flex agreements in your favor, and help you take decisive action on what matters. | Technology Services |
